The psychedelic treatment, for PTSD, was rejected last week by government regulators.
Related Posts
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages…
Six Childhood Scourges We’ve Forgotten About, Thanks to Vaccines
Most Americans, including doctors, have no memory of the devastating diseases that routinely threatened children until the 1960s.
‘Vaguely Threatening’: Federal Prosecutor Queries Leading Medical Journal
The New England Journal of Medicine received a letter suggesting that it was biased and compromised by external pressure. Other…
